首页> 外文期刊>BMC Nephrology >Prevalence, determinants and co-morbidities of chronic kidney disease among First Nations adults with diabetes: results from the CIRCLE study
【24h】

Prevalence, determinants and co-morbidities of chronic kidney disease among First Nations adults with diabetes: results from the CIRCLE study

机译:原住民糖尿病成年人中慢性肾脏病的患病率,决定因素和合并症:CIRCLE研究结果

获取原文
           

摘要

Background Indigenous peoples worldwide are experiencing elevated rates of type 2 diabetes and its complications. To better understand the disproportionate burden of diabetic end stage renal disease (ESRD) among Canadian First Nations people (FN), we examined prevalence, determinants, and co-morbidities of chronic kidney disease (CKD) within this population. Methods The 2007 Canadian FN Diabetes Clinical Management and Epidemiologic (CIRCLE) study conducted a cross-sectional national medical chart audit of 885 FN adults with type 2 diabetes to assess quality of diabetes care. In this sub-study, participants were divided by estimated glomerular filtration rate (eGFR in ml/min/1.73?m2), as well as by albuminuria level in those with eGFRs =?>?60. Those with eGFRs =?>?60 and negative albuminuria were considered to have normalear normal kidney function (non-CKD). Using univariate and logistic regression analysis, they were compared with participants having eGFRs =?>?60 plus albuminuria (CKD-alb) and with participants having eGFRs Results While 84.5% of total CIRCLE participants had eGFRs =?>?60, almost 60% of the latter had CKD-alb. Of the 15.5% of total participants with CKD-eGFR Conclusions High prevalences of CKD-alb and early CKD-eGFR
机译:背景技术全世界的土著人民正在经历2型糖尿病及其并发症的高发病率。为了更好地了解加拿大原住民(FN)中糖尿病末期肾病(ESRD)的不成比例负担,我们检查了该人群中慢性肾脏病(CKD)的患病率,决定因素和合并症。方法2007年加拿大FN糖尿病临床管理和流行病学(CIRCLE)研究对885名2型糖尿病FN成人进行了横断面全国医学图表审计,以评估糖尿病的护理质量。在本子研究中,参与者被除以估计的肾小球滤过率(eGFR以ml / min / 1.73?m 2 为单位),以及eGFR≥?60的白蛋白尿水平。那些eGFRs≥α≥60且白蛋白尿阴性的人被认为具有正常/接近正常的肾功能(非CKD)。使用单变量和logistic回归分析,将他们与eGFR≥?60加上白蛋白尿(CKD-alb)的参与者和具有eGFR的参与者进行了比较。结果,在总CIRCLE参与者中84.5%的eGFR≥?60,几乎有60%后者有CKD-alb。在CKD-eGFR总参与者中15.5%的结论结论CKD-alb和早期CKD-eGFR的高患病率

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号